This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Huang - Innovator in Pharmaceutical Compounds
Introduction
David Huang is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific cancer-related proteins. His work is crucial in the ongoing fight against various forms of cancer.
Latest Patents
David Huang holds a patent for "Heterocyclic spiro compounds and methods of use." This patent includes compounds of Formula (I) that exhibit activity as inhibitors of the G12C mutant KRAS protein. The pharmaceutical compositions derived from these compounds are designed for treating disorders such as lung, pancreatic, and colorectal cancers.
Career Highlights
Huang is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
One of his notable coworkers is Brian Alan Lanman. Together, they work on advancing the understanding and treatment of cancer through innovative pharmaceutical solutions.
Conclusion
David Huang's contributions to the field of pharmaceuticals, particularly through his patent on heterocyclic spiro compounds, highlight his role as an important inventor in the fight against cancer. His work at Amgen Inc. continues to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile